24 results on '"Schendel Dolores J"'
Search Results
2. TCR-transgenic lymphocytes specific for HMMR/Rhamm limit tumor outgrowth in vivo
3. Effective and long-term control of EBV PTLD after transfer of peptide-selected T cells
4. Dendritic cells pulsed with RNA encoding allogeneic MHC and antigen induce T cells with superior antitumor activity and higher TCR functional avidity
5. Effects of galactooligosaccharide and long-chain fructooligosaccharide supplementation during pregnancy on maternal and neonatal microbiota and immunity—a randomized, double-blind, placebo-controlled study
6. Quantitative and functional impairment of pulmonary CD4 +CD25 hi regulatory T cells in pediatric asthma
7. Association between levels of Toll-like receptors 2 and 4 and CD14 mRNA and allergy in pregnant women and their offspring
8. Frequency of Vα24+CD161+ natural killer T cells and invariant TCRAV24-AJ18 transcripts in atopic and non-atopic individuals
9. Allogeneic MHC class I ligands and their role in positive and negative regulation of human cytotoxic effector cells
10. 407 - Long Term Follow up of a “Fast-DC” Immunotherapy Against WT-1 and PRAME As a Post-Remission Strategy for AML
11. Non-MHC-restricted CD4 + T lymphocytes are regulated by HLA-Cw7-mediated inhibition
12. PRAME mRNA Expression in AML/MDS and HLA Genotype Analysis: Impact on Population Coverage and Design of TCR-Based Immunotherapies
13. AML Patients in Minimal Residual Disease Vaccinated with a Novel Generation of Fast Dendritic Cells Expressing WT-1 and PRAME Mount Specific Immune Responses That Relate to Clinical Outcome
14. Vaccination with a New Generation of Fast Dendritic Cells Transfected with mRNA from hTERT, Survivin and Autologous Tumor Mount Strong Immune Responses and Prolong Survival
15. Improving Efficacy of Dendritic Cell Vaccination in AML: Optimization of the DC Generation Protocol and Maximization of T Cell Responses by Immune Checkpoint Blockade
16. Dendritic Cells Matured with a TLR7/8 Agonist Induce T Helper 1 Cell Polarization, Activate NK Cells and Are Thus Highly Suitable for Application in Cancer Immunotherapy
17. IMMUNE MONITORING OF AN ALLOGENIC GENETICALLY- MODIFIED TUMOR CELL VACCINE (RCC-26/CD80/IL-2) IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA
18. Graft-versus-leukemia reactions in allogeneic chimeras
19. Biochemical and cellular identification of HLA-Bw44 subtypes
20. Noncodominant expression of target antigens recognized by human cytotoxic T lymphocytes
21. Production of human T cell growth factor
22. Enhanced expression of HLA-class II molecules on activated human T lymphocytes following treatment with tumor necrosis factor alpha
23. Microheterogeneity in HLA-B35 alleles influences peptide-dependent allorecognition by cytotoxic T cells but not binding of a peptide-restricted monoclonal antibody
24. On the peptide model of allorecognition: Cytotoxic T lymphocytes recognize an alloantigen encoded by two HLA-linked genes
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.